NRSNVSREFR• 12 Months (Normalized)
NRSN vs REFR (NeuroSense Therapeutics Ltd. vs Research Frontiers Incorporated)
Showing Closing Date Range from Oct 2, 2025 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
NRSN Performance $3.94
+219.92%
NeuroSense Therapeutics Ltd.
Normalized Baseline0.00%
REFR Performance $0.73
-49.75%
Research Frontiers Incorporated
Normalized Baseline0.00%
Alpha Spread Margin NRSN LEADS
+269.67 pts
NRSN outperforming by 269.67 percentage points
NRSNREFR
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
NRSN REFR
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(250 dates)
| Date | NRSN Price | NRSN Gain (%) | REFR Price | REFR Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $3.94 | +219.92% | $0.73 | -49.75% | +269.67% |
| Sep 29, 2026 | $4.78 | +288.62% | $- | - | |
| Sep 28, 2026 | $5.10 | +314.63% | $- | - | |
| Sep 25, 2026 | $6.95 | +465.04% | $- | - | |
| Sep 24, 2026 | $7.40 | +501.63% | $0.74 | -48.92% | +550.55% |
| Sep 23, 2026 | $7.40 | +501.63% | $0.71 | -51.03% | +552.66% |
| Sep 22, 2026 | $7.18 | +483.74% | $0.78 | -46.21% | +529.95% |
| Sep 21, 2026 | $6.62 | +438.21% | $0.76 | -47.59% | +485.80% |
| Sep 18, 2026 | $6.35 | +416.26% | $0.65 | -55.17% | +471.43% |
| Sep 17, 2026 | $6.72 | +446.34% | $0.39 | -73.10% | +519.44% |
| Sep 16, 2026 | $6.49 | +427.64% | $0.38 | -73.79% | +501.43% |
| Sep 15, 2026 | $7.03 | +471.54% | $0.36 | -75.17% | +546.71% |
| Sep 14, 2026 | $6.90 | +460.98% | $0.38 | -73.79% | +534.77% |
| Sep 11, 2026 | $0.35 | -71.79% | $0.39 | -73.10% | +1.31% |
| Sep 10, 2026 | $0.33 | -73.01% | $0.39 | -73.10% | +0.09% |
Page 1 of 17